Osteoarthritis
Osteoarthritis affects around 10 million people in the UK. Guide to OA causes, joint symptoms and diagnosis.
2-minute consultation reviewed by a UK clinician
We check your answers and recommend a suitable option
Plain packaging to your door, fast and confidential
Osteoarthritis UK: Symptoms, Joints Affected & Management
A clinically reviewed UK conditions guide to osteoarthritis — who gets it, joints affected, causes and risk factors, diagnosis, disease staging, and evidence-based treatment options.
Osteoarthritis (OA) is the most common form of arthritis and the most common chronic joint condition in the UK, affecting around 10 million people. It is a disease of the whole joint — not simply cartilage wear — involving progressive structural change with an active inflammatory component. It is manageable: the right combination of exercise, weight management, and targeted treatment allows most people to maintain function and reduce pain significantly.
What Is Osteoarthritis?
Osteoarthritis is a chronic joint disease characterised by the progressive breakdown of articular cartilage — the smooth tissue that covers the ends of bones within a joint — alongside changes to the underlying bone, joint lining, ligaments, and surrounding muscles. It is not simply “wear and tear” (a term that is both imprecise and unhelpfully fatalistic) — it involves active biological processes including low-grade inflammation that contribute to pain and structural change.
The distinction matters clinically. OA flares have a genuine inflammatory component, which is why anti-inflammatory treatment is effective during flares. But OA is not primarily an inflammatory disease in the same way as rheumatoid arthritis — the inflammation is secondary to structural joint change rather than driving it. This means the treatment approach differs: exercise and load management are as important as medication.
Who Gets Osteoarthritis?
OA becomes significantly more prevalent with age — it is uncommon before 45 and very common over 65. However, it is not an inevitable consequence of ageing: many people in their 80s have minimal OA, while others develop significant OA in their 40s or 50s. Age is a risk factor, not a cause.
OA is more common in women than men, particularly for hand and knee OA. The sex difference becomes more pronounced after the menopause, suggesting oestrogen plays a protective role in joint health.
Joints Most Commonly Affected
| Joint | Key features |
|---|---|
| Knee | Most common OA site; medial compartment most frequently affected; bilateral in ~50% of cases. Pain on stairs, squatting, and prolonged walking; stiffness after rest. |
| Hip | Deep groin or buttock pain; reduced range of movement; gait changes; significant functional impact. Often requires hip replacement when severe. |
| Hand | Distal and proximal interphalangeal joints; first carpometacarpal joint (base of thumb). Heberden’s and Bouchard’s nodes; reduced grip strength; may limit fine motor tasks. |
| Spine (facet joints) | Contributes to chronic back and neck pain; osteophyte formation can narrow the spinal canal (spinal stenosis) and compress nerve roots. |
| First metatarsophalangeal joint | Base of the big toe; hallux rigidus; pain with walking and push-off. |
Causes and Risk Factors
- Age — the single strongest risk factor; cumulative joint loading over time and reduced cartilage repair capacity
- Obesity — strongly associated with knee and hip OA; each kilogram of body weight imposes approximately 3–5kg of force on the knee during walking; also has metabolic and inflammatory effects independent of load
- Previous joint injury — anterior cruciate ligament tears, meniscal injuries, and intra-articular fractures substantially increase future OA risk in the affected joint
- Occupational factors — jobs involving repetitive kneeling, squatting, or heavy lifting increase knee and hip OA risk
- Genetics — significant hereditary component, particularly for hand and hip OA; first-degree relatives of OA patients have 2–3× higher risk
- Joint malalignment — varus (bow-legged) or valgus (knock-kneed) alignment increases compartmental loading; joint dysplasia increases hip OA risk
- Sex — women, particularly post-menopausal, have higher rates of OA
Symptoms
- Joint pain — typically a deep, aching pain; worsened by activity and weight-bearing; relieved by rest (though severe OA causes rest pain and night pain)
- Morning stiffness — characteristically brief (<30 minutes); longer morning stiffness suggests inflammatory arthritis rather than OA
- Stiffness after inactivity — “gelling”; stiffness on rising from a chair or after prolonged sitting; improves quickly with movement
- Crepitus — a grating, creaking, or grinding sensation within the joint; caused by articular surface irregularity
- Reduced range of movement — joint feels stiff and restricted; functional consequences depend on the joint affected
- Joint swelling — can occur, particularly in knee OA; combination of osteophytes (bony enlargement), synovitis, and effusion
- Flares — intermittent episodes of increased pain and swelling lasting days to weeks; often precipitated by overactivity, minor trauma, or changes in weather
OA symptoms can vary enormously. Structural changes on imaging do not reliably predict pain — some people with severe X-ray changes have minimal symptoms, and vice versa. The most important measure is functional impact: how much does the pain affect daily activities, sleep, and quality of life?
Diagnosis
OA is diagnosed clinically in most cases. NICE guidance states that OA can be diagnosed in adults over 45 with activity-related joint pain and either no morning stiffness or morning stiffness lasting less than 30 minutes — without requiring investigations. X-ray can confirm the diagnosis and grade severity but is not required for initial management.
Classic X-ray features of OA are: LOSS — Loss of joint space, Osteophytes, Subchondral sclerosis, Subchondral cysts. MRI is rarely needed for OA management but may be used to assess meniscal or ligament pathology in younger patients or when considering surgery.
Blood tests are normal in OA and are used mainly to exclude inflammatory arthritis (negative RF, normal CRP and ESR in OA).
Disease Stages
| Stage (Kellgren & Lawrence) | X-ray features | Clinical picture |
|---|---|---|
| Grade 1 — Doubtful | Possible osteophytes; normal joint space | Intermittent aching; mild stiffness |
| Grade 2 — Mild | Definite osteophytes; normal or slightly reduced joint space | Moderate pain with activity; brief morning stiffness |
| Grade 3 — Moderate | Multiple osteophytes; joint space narrowing; sclerosis | Regular pain; functional limitation; flares |
| Grade 4 — Severe | Large osteophytes; significant joint space narrowing; deformity | Constant pain; significant disability; rest pain; may need surgery |
Treatment Overview
The core of OA management is non-pharmacological. Exercise — land-based and aquatic — is the single most evidence-based intervention for OA and more effective than many medicines for long-term outcomes. Weight management is equally important for lower-limb OA.
| Treatment | Evidence | Notes |
|---|---|---|
| Exercise therapy | Strong | Strengthening, aerobic, and range-of-movement exercise; reduces pain and improves function; should be offered to all OA patients |
| Weight management | Strong (knee/hip) | 5–10% weight loss produces clinically meaningful symptom improvement in knee and hip OA |
| Topical diclofenac gel | Strong | NICE first-line for knee and hand OA; delivers NSAID directly to the joint with minimal systemic side effects |
| Oral NSAIDs | Good | Effective for OA flares; lowest effective dose with PPI; naproxen or ibuprofen |
| Paracetamol | Modest | NICE no longer recommends long-term paracetamol as first-line for OA (limited evidence for long-term benefit); useful for acute flares alongside NSAIDs |
| Intra-articular steroid injection | Short-term benefit | Effective for acute flares; effect lasts weeks to months; specialist/GP-administered |
| Joint replacement | Strong (end-stage) | Total knee and hip replacement are among the most cost-effective surgical procedures; indicated when conservative management has failed and quality of life is severely impaired |
Prescription diclofenac gel (NICE first-line for knee OA) and oral NSAIDs for OA flares: Prescription pain relief at Access Doctor →
For topical vs oral NSAID comparison for OA: Diclofenac gel guide → · NSAIDs compared →
When to Seek Help
- Joint pain significantly affecting your daily activities, sleep, or quality of life
- Sudden severe worsening of a joint that was previously manageable — may indicate an acute flare, crystal arthropathy, or haemarthrosis
- Joint that becomes hot, red, and acutely swollen — possible septic arthritis (infected joint), which requires emergency assessment
- Progressive loss of joint function despite conservative management — orthopaedic referral for consideration of joint replacement
Frequently Asked Questions
What is osteoarthritis?
Osteoarthritis is the most common joint disease, affecting around 10 million people in the UK. It involves progressive breakdown of articular cartilage and structural joint changes, with a low-grade inflammatory component that drives pain during flares. It most commonly affects the knee, hip, hands, and spine.
What causes osteoarthritis?
The main risk factors are age (strongest factor), obesity (particularly for knee and hip OA), previous joint injury, genetics, occupational loading, and joint malalignment. OA is not simply a consequence of ageing — it involves active biological processes and many older adults have minimal joint disease.
What is the best treatment for osteoarthritis?
Exercise therapy is the single most evidence-based intervention for OA and is more effective long-term than most medicines. Weight management is equally important for lower-limb OA. For symptom control, topical diclofenac gel is NICE first-line for knee and hand OA; oral NSAIDs are used for flares. Joint replacement is considered in severe disease that has not responded to conservative management.
Is diclofenac gel good for osteoarthritis?
Yes. Topical diclofenac gel is endorsed by NICE as first-line treatment for knee and hand OA specifically. It delivers the anti-inflammatory agent directly to the joint, achieving effective local concentrations with much lower systemic absorption than oral NSAIDs — meaning fewer gastrointestinal, renal, and cardiovascular side effects.
Can I get prescription treatment for osteoarthritis online?
Yes. Prescription diclofenac gel (2.32%) and oral NSAIDs (naproxen, ibuprofen 600mg) for OA are available at Access Doctor following an online consultation with GPhC-registered pharmacist independent prescribers. GPhC pharmacy #9011198.
References
- NICE. Osteoarthritis: care and management. CG177. 2014 (updated 2022). nice.org.uk/guidance/cg177
- NICE CKS. Osteoarthritis. Updated 2023. cks.nice.org.uk
- NHS. Osteoarthritis. nhs.uk/conditions/osteoarthritis
- Versus Arthritis. Osteoarthritis. versusarthritis.org
Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional. In a medical emergency, call 999.


